Arcturus Therapeutics Ltd. Additional Paid in Capital
Arcturus Therapeutics Ltd. had Additional Paid in Capital of $58.70 million as of 2019-03-31, per its 10-Q filed 2019-05-13.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapital · last filed 2019-05-13
- 2019-03-31: Additional Paid in Capital $58.70M.
- 2018-12-31: Additional Paid in Capital $58.30M.
- 2018-09-30: Additional Paid in Capital $57.80M.
- 2018-06-30: Additional Paid in Capital $57.19M.
| Period end | Additional Paid in Capital | Additional Paid in Capital as first filed |
|---|---|---|
| 2019-03-31 | $58.70M 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $58.30M 10-Q · filed 2019-05-13 | |
| 2018-09-30 | $57.80M 6-K · filed 2018-11-07 | |
| 2018-06-30 | $57.19M 6-K · filed 2018-09-28 | |
| 2017-12-31 | $56.67M 10-K · filed 2019-03-18 | |
| 2016-12-31 | $13.76M 20-F · filed 2018-05-14 | $142.78M 20-F · filed 2017-04-28 |
| 2015-12-31 | $140.27M 20-F · filed 2017-04-28 | |
| 2014-12-31 | $71.47M 20-F · filed 2016-03-04 | |
| 2013-12-31 | $67.38M 20-F · filed 2015-02-27 | |
| 2012-12-31 | $7.62M 20-F · filed 2014-03-28 |